LENZ Therapeutics, Inc. (LENZ)
4.59
-0.09
(-1.92%)
USD |
NASDAQ |
Aug 24, 16:00
4.60
+0.01
(+0.22%)
After-Hours: 20:00
LENZ Therapeutics Market Cap : 144.20M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 144.20M |
| August 21, 2026 | 147.03M |
| August 20, 2026 | 146.40M |
| August 19, 2026 | 154.57M |
| August 18, 2026 | 149.86M |
| August 17, 2026 | 150.49M |
| August 14, 2026 | 148.60M |
| August 13, 2026 | 144.52M |
| August 12, 2026 | 158.34M |
| August 11, 2026 | 163.68M |
| August 10, 2026 | 168.39M |
| August 07, 2026 | 168.39M |
| August 06, 2026 | 164.00M |
| August 05, 2026 | 165.24M |
| August 04, 2026 | 158.34M |
| August 03, 2026 | 156.62M |
| July 31, 2026 | 166.18M |
| July 30, 2026 | 180.60M |
| July 29, 2026 | 179.35M |
| July 28, 2026 | 184.36M |
| July 27, 2026 | 178.72M |
| July 24, 2026 | 171.82M |
| July 23, 2026 | 158.34M |
| July 22, 2026 | 167.43M |
| July 21, 2026 | 161.79M |
| Date | Value |
|---|---|
| July 20, 2026 | 155.52M |
| July 17, 2026 | 162.42M |
| July 16, 2026 | 153.01M |
| July 15, 2026 | 156.46M |
| July 14, 2026 | 154.58M |
| July 13, 2026 | 163.98M |
| July 10, 2026 | 175.27M |
| July 09, 2026 | 181.54M |
| July 08, 2026 | 192.20M |
| July 07, 2026 | 184.99M |
| July 06, 2026 | 175.58M |
| July 02, 2026 | 184.68M |
| July 01, 2026 | 181.54M |
| June 30, 2026 | 178.09M |
| June 29, 2026 | 180.60M |
| June 26, 2026 | 182.48M |
| June 25, 2026 | 172.76M |
| June 24, 2026 | 174.96M |
| June 23, 2026 | 180.29M |
| June 22, 2026 | 182.48M |
| June 18, 2026 | 192.83M |
| June 17, 2026 | 198.79M |
| June 16, 2026 | 204.43M |
| June 15, 2026 | 207.88M |
| June 12, 2026 | 212.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ocular Therapeutix, Inc. | 2.367B |
| Enveric Biosciences, Inc. | 5.550M |
| Liquidia Corp. | 6.261B |
| Aquestive Therapeutics, Inc. | 602.46M |
| Impact BioMedical, Inc. | 48.84M |
Market Cap Related Metrics
| PS Ratio | 6.537 |
| PEG Ratio | -0.0098 |
| Price to Book Value | 0.6577 |
| Price | 4.59 |
| Earnings Yield | -88.91% |
| PEGY Ratio | -0.0098 |